BIOMAT Database Logo BIOMAT Database Logo

The diagnosis of growth hormone deficiency (GHD) in adults. 1995

M O Thorner, and B A Bengtsson, and K Y Ho, and K Albertsson-Wikland, and J S Christiansen, and G Faglia, and M Irie, and O Isaksson, and J O Jörgensen, and M Ranke

UI MeSH Term Description Entries
D007334 Insulin-Like Growth Factor I A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor. IGF-I,Somatomedin C,IGF-1,IGF-I-SmC,Insulin Like Growth Factor I,Insulin-Like Somatomedin Peptide I,Insulin Like Somatomedin Peptide I
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D004392 Dwarfism A genetic or pathological condition that is characterized by short stature and undersize. Abnormal skeletal growth usually results in an adult who is significantly below the average height. Nanism
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013006 Growth Hormone A polypeptide that is secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Growth hormone, also known as somatotropin, stimulates mitosis, cell differentiation and cell growth. Species-specific growth hormones have been synthesized. Growth Hormone, Recombinant,Pituitary Growth Hormone,Recombinant Growth Hormone,Somatotropin,Somatotropin, Recombinant,Growth Hormone, Pituitary,Growth Hormones Pituitary, Recombinant,Pituitary Growth Hormones, Recombinant,Recombinant Growth Hormones,Recombinant Pituitary Growth Hormones,Recombinant Somatotropins,Somatotropins, Recombinant,Growth Hormones, Recombinant,Recombinant Somatotropin
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D017410 Practice Guidelines as Topic Works about directions or principles presenting current or future rules of policy for assisting health care practitioners in patient care decisions regarding diagnosis, therapy, or related clinical circumstances. The guidelines may be developed by government agencies at any level, institutions, professional societies, governing boards, or by the convening of expert panels. The guidelines form a basis for the evaluation of all aspects of health care and delivery. Clinical Guidelines as Topic,Best Practices,Best Practice
D018972 Insulin-Like Growth Factor Binding Protein 3 One of the six homologous soluble proteins that bind insulin-like growth factors (SOMATOMEDINS) and modulate their mitogenic and metabolic actions at the cellular level. IGF-Binding Protein 3,IGFBP-3,IGF Binding Protein 3,Protein 3, IGF-Binding

Related Publications

M O Thorner, and B A Bengtsson, and K Y Ho, and K Albertsson-Wikland, and J S Christiansen, and G Faglia, and M Irie, and O Isaksson, and J O Jörgensen, and M Ranke
Laboratory diagnosis of growth hormone deficiency (GHD).
January 2009, Journal of pediatric endocrinology & metabolism : JPEM,
M O Thorner, and B A Bengtsson, and K Y Ho, and K Albertsson-Wikland, and J S Christiansen, and G Faglia, and M Irie, and O Isaksson, and J O Jörgensen, and M Ranke
Adult growth hormone deficiency (GHD): an established diagnosis?
September 2008, Journal of endocrinological investigation,
M O Thorner, and B A Bengtsson, and K Y Ho, and K Albertsson-Wikland, and J S Christiansen, and G Faglia, and M Irie, and O Isaksson, and J O Jörgensen, and M Ranke
The diagnosis of growth hormone deficiency (GHD) in successfully treated acromegalic patients.
January 2001, Clinical endocrinology,
M O Thorner, and B A Bengtsson, and K Y Ho, and K Albertsson-Wikland, and J S Christiansen, and G Faglia, and M Irie, and O Isaksson, and J O Jörgensen, and M Ranke
Evaluation of permanent growth hormone deficiency (GHD) in young adults with childhood onset GHD: a multicenter study.
January 2008, Journal of clinical research in pediatric endocrinology,
M O Thorner, and B A Bengtsson, and K Y Ho, and K Albertsson-Wikland, and J S Christiansen, and G Faglia, and M Irie, and O Isaksson, and J O Jörgensen, and M Ranke
Confirming the diagnosis of growth hormone deficiency (GHD) and transitioning the care of patients with childhood-onset GHD.
May 2003, Journal of pediatric endocrinology & metabolism : JPEM,
M O Thorner, and B A Bengtsson, and K Y Ho, and K Albertsson-Wikland, and J S Christiansen, and G Faglia, and M Irie, and O Isaksson, and J O Jörgensen, and M Ranke
Growth hormone deficiency (GHD) in adult thalassaemic patients.
November 2007, Clinical endocrinology,
M O Thorner, and B A Bengtsson, and K Y Ho, and K Albertsson-Wikland, and J S Christiansen, and G Faglia, and M Irie, and O Isaksson, and J O Jörgensen, and M Ranke
Psychometric Validation of the Growth Hormone Deficiency-Child Treatment Burden Measure (GHD-CTB) and the Growth Hormone Deficiency-Parent Treatment Burden Measure (GHD-PTB).
January 2023, PharmacoEconomics - open,
M O Thorner, and B A Bengtsson, and K Y Ho, and K Albertsson-Wikland, and J S Christiansen, and G Faglia, and M Irie, and O Isaksson, and J O Jörgensen, and M Ranke
Assessing the Impact of Growth Hormone Deficiency (GHD) in Adults: Interpreting Change of the Treatment-Related Impact Measure-Adult Growth Hormone Deficiency (TRIM-AGHD).
March 2019, PharmacoEconomics - open,
M O Thorner, and B A Bengtsson, and K Y Ho, and K Albertsson-Wikland, and J S Christiansen, and G Faglia, and M Irie, and O Isaksson, and J O Jörgensen, and M Ranke
The diagnosis of growth hormone deficiency in adults.
October 1997, The Journal of clinical endocrinology and metabolism,
M O Thorner, and B A Bengtsson, and K Y Ho, and K Albertsson-Wikland, and J S Christiansen, and G Faglia, and M Irie, and O Isaksson, and J O Jörgensen, and M Ranke
Diagnosis of growth hormone deficiency in adults.
June 1994, Lancet (London, England),
Copied contents to your clipboard!